Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment — Stella

Home/Gastroesophageal Reflux Disease (GERD)/Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment

View on ClinicalTrials.gov

Recruiting

Back to Gastroesophageal Reflux Disease (GERD) trials

Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment

Trial locations(6 sites)

Germany

Klinikum Friedrichshafen GmbH, Friedrichshafen

Italy

Ospedale IRCCS Saverio De Bellis, Bari

Ospedale Buon Consiglio Fatebenefratelli, Naples

Norway

Akershus Universitetssykehus HF, Lørenskog

Switzerland

Inselspital, Universitätsspital Bern, Bern

Hirslanden Klinik, Bern

Key details

Sponsor

Implantica CE Reflux Ltd.

Enrollment target

~2,500 participants

Started

February 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.